Additional file 3: of Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer

Table S3. Patient characteristics. The table shows the characteristics of the 73 patients included in the study. Abbreviations: ER Estrogen receptor, HER2 Human epidermal growth factor receptor 2, ID Invasive ductal, IL Invasive lobular, NA Not available, PR Progesterone receptor, ECOG Eastern Cooperative Oncology Group (as defined by Oken et al. [24]). (XLSX 14 kb)